California State Teachers Retirement System Has $7.39 Million Holdings in Shockwave Medical, Inc. (NASDAQ:SWAV)

California State Teachers Retirement System lessened its stake in Shockwave Medical, Inc. (NASDAQ:SWAVFree Report) by 4.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 38,760 shares of the company’s stock after selling 1,702 shares during the quarter. California State Teachers Retirement System owned approximately 0.11% of Shockwave Medical worth $7,386,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Asset Management One Co. Ltd. acquired a new stake in shares of Shockwave Medical in the 4th quarter valued at approximately $34,000. Quest Partners LLC acquired a new stake in shares of Shockwave Medical in the 4th quarter valued at approximately $41,000. Operose Advisors LLC acquired a new stake in shares of Shockwave Medical in the 3rd quarter valued at approximately $49,000. Covestor Ltd boosted its holdings in shares of Shockwave Medical by 484.9% in the 3rd quarter. Covestor Ltd now owns 427 shares of the company’s stock valued at $85,000 after buying an additional 354 shares during the last quarter. Finally, Principal Securities Inc. acquired a new stake in shares of Shockwave Medical in the 4th quarter valued at approximately $106,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Buying and Selling at Shockwave Medical

In other Shockwave Medical news, Director Laura Francis sold 1,500 shares of Shockwave Medical stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $300.00, for a total value of $450,000.00. Following the transaction, the director now owns 3,551 shares in the company, valued at $1,065,300. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Shockwave Medical news, Director Laura Francis sold 1,500 shares of Shockwave Medical stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $300.00, for a total value of $450,000.00. Following the transaction, the director now owns 3,551 shares in the company, valued at $1,065,300. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Isaac Zacharias sold 4,000 shares of Shockwave Medical stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $287.67, for a total value of $1,150,680.00. Following the completion of the transaction, the insider now owns 56,818 shares in the company, valued at approximately $16,344,834.06. The disclosure for this sale can be found here. Company insiders own 3.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on SWAV. TheStreet raised Shockwave Medical from a “c+” rating to a “b” rating in a report on Thursday, February 15th. Needham & Company LLC reaffirmed a “hold” rating on shares of Shockwave Medical in a report on Friday, April 5th. Canaccord Genuity Group reaffirmed a “hold” rating and set a $335.00 price target (up previously from $263.00) on shares of Shockwave Medical in a report on Friday, April 5th. Morgan Stanley reaffirmed an “equal weight” rating and set a $335.00 price target (up previously from $285.00) on shares of Shockwave Medical in a report on Monday, April 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $335.00 price target (up previously from $270.00) on shares of Shockwave Medical in a report on Monday, April 8th. Ten analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Shockwave Medical has an average rating of “Hold” and an average target price of $309.11.

Get Our Latest Analysis on Shockwave Medical

Shockwave Medical Stock Down 0.0 %

SWAV stock opened at $334.75 on Monday. The company has a debt-to-equity ratio of 0.97, a current ratio of 13.81 and a quick ratio of 12.61. The stock has a market capitalization of $12.57 billion, a price-to-earnings ratio of 78.21, a PEG ratio of 2.43 and a beta of 0.88. The business’s fifty day moving average price is $329.87 and its two-hundred day moving average price is $263.22. Shockwave Medical, Inc. has a fifty-two week low of $157.00 and a fifty-two week high of $334.90.

Shockwave Medical (NASDAQ:SWAVGet Free Report) last issued its quarterly earnings results on Monday, May 6th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.45. Shockwave Medical had a return on equity of 24.79% and a net margin of 20.75%. The company had revenue of $218.80 million for the quarter, compared to analysts’ expectations of $207.69 million. During the same quarter last year, the business earned $1.03 earnings per share. Shockwave Medical’s revenue was up 35.8% on a year-over-year basis. On average, equities analysts anticipate that Shockwave Medical, Inc. will post 5.05 earnings per share for the current year.

Shockwave Medical Profile

(Free Report)

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.

See Also

Want to see what other hedge funds are holding SWAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shockwave Medical, Inc. (NASDAQ:SWAVFree Report).

Institutional Ownership by Quarter for Shockwave Medical (NASDAQ:SWAV)

Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.